We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cardiothoracic Imaging Algorithm Automates Ventricular Assessment

By HospiMedica International staff writers
Posted on 31 Mar 2021
A novel algorithm enables measurement of the cardiac ventricles and calculation of the associated RV/LV ratio from CT images. More...


The Imbio (Minneapolis, MN, USA) RV/LV Analysis algorithm is a rapid, automated assessment tool that quickly and accurately measures the ventricles of the heart via quantitative evaluation of four-chamber computed tomography (CT) axial images in order to provide the ratio between the maximum diameter of the RV, as compared to LV diameter, which can be indicative of several pulmonary and cardiopulmonary diseases, such as pulmonary embolism (PE), and can aid in risk stratification.

The RV/LV ratio results are added directly to the patient’s imaging study, and within minutes of the analysis. In addition to real-time RV/LV ratio, varying causes of right ventricular dilatation may also be captured earlier, if RV/LV automation is routinely implemented within native clinical imaging workflows. With the ability to run the automated analysis and have results available at the time of the initial clinical reading, it may potentially save reporting time as well.

“Imbio is proud to deliver this AI-driven algorithm to clinicians and our partners to support acute cases and assist in key treatment decisions for patients,” said David Hannes, CEO of Imbio. “Our automated RV/LV Analysis has the power to provide vital information and inform risk stratification in many acute cases. We believe that the routine use of the RV/LV Analysis in clinical practice can also enable more consistent, quantitative reporting of potential right heart strain for all CTPA exams.”

“Reporting right heart strain on CT pulmonary angiogram studies positive for pulmonary embolism, despite what we are inclined to think, is frequently done inconsistently, incorrectly, or not at all,” said radiologist Jonathan Rodrigues, MD, of the Royal United Hospitals Bath NHS Foundation Trust (United Kingdom). “We have shown Imbio's RV/LV Analysis to work consistently in unselected real-world cases and have demonstrated how it could alter management, as well as potentially predict all-cause mortality.”

Quantitative cardiac CT measurements obtained on axial CT images, namely the RV short axis, the LV short axis, and particularly the RV/LV short axes ratio, have shown a significant positive correlation with the severity of PE; an RV/LV diameter ratio superior to 1.5 indicates a severe episode of PE. In addition, an RV/LV diameter ratio greater than 0.9 can be used to predict the occurrence of a range of adverse clinical events, such as 30-day mortality, the need for cardiopulmonary resuscitation (CPR), mechanical ventilation, and more.

Related Links:
Imbio


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.